share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：拟议出售证券
美股sec公告 ·  06/05 12:31
Moomoo AI 已提取核心信息
Christopher Gibson, an officer and director at Recursion Pharmaceuticals, Inc., is set to sell 50,000 Class A shares of the company, with an aggregate market value of $421,000, on 06/05/2024. These shares were originally acquired on 09/01/2016 as founders shares, a form of compensation from the issuer. This planned transaction follows a series of sales over the past three months, where Gibson sold a total of 356,319 shares, amounting to gross proceeds of approximately $3.35 million.
Christopher Gibson, an officer and director at Recursion Pharmaceuticals, Inc., is set to sell 50,000 Class A shares of the company, with an aggregate market value of $421,000, on 06/05/2024. These shares were originally acquired on 09/01/2016 as founders shares, a form of compensation from the issuer. This planned transaction follows a series of sales over the past three months, where Gibson sold a total of 356,319 shares, amounting to gross proceeds of approximately $3.35 million.
Recursion Pharmaceuticals, Inc. 的一位官员和董事 Christopher Gibson 打算于 2024 年 06 月 05 日卖出 50,000 股 A 类股份，市值总计 421,000 美元。这些股份最初是在 2016 年 09 月 01 日作为创始者股份从发行人处获得的一种补偿形式。这一计划中的交易是在过去三个月销售的一系列交易之后进行的，Gibson 共出售了 356,319 股股票，总销售额约为 335 万美元。
Recursion Pharmaceuticals, Inc. 的一位官员和董事 Christopher Gibson 打算于 2024 年 06 月 05 日卖出 50,000 股 A 类股份，市值总计 421,000 美元。这些股份最初是在 2016 年 09 月 01 日作为创始者股份从发行人处获得的一种补偿形式。这一计划中的交易是在过去三个月销售的一系列交易之后进行的，Gibson 共出售了 356,319 股股票，总销售额约为 335 万美元。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息